Verification phase for Calmark's first product completed
The verification phase of the development project for Calmark Sweden AB's (publ) first product, Neo-Bilirubin, was completed today with successful results from all sub-phases regarding the function and performance of the product.CE conformity marking and the development of medical technology products follows a seven-step process, where the first three steps involve identification of requirements specification and development to cover them. The product is then verified against the prescribed requirements and validated by potential end users (steps four and five). The development project is